Fellow in Hematology/Oncology
Exploring the therapeutic potential of HDAC11 inhibitors in the treatment of multiple myeloma.
Exploring the potential for selective HDAC11 inhibitors to enhance T cell responses in the context of immunotherapy, including vaccine-based and cellular adoptive therapeutic approaches.
Defining the functional significance of the interaction between HDAC11 and IRF4 and its impact as a regulator of CD8 T cell function.Defining the functional significance of the interaction between HDAC11 and IRF4 as it relates to myeloma cell development and survival.
years treating myeloma: 12
Number of Myeloma Patients Treated Annually: 1000
Details & contact info
H. Lee Moffitt Cancer Center (MCC) USF Citrus Drive
Tampa, FL, United States, 33620
Send a message to Jason Brayer MD, PHD